1. Home
  2. CELU vs ICCM Comparison

CELU vs ICCM Comparison

Compare CELU & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celularity Inc.

CELU

Celularity Inc.

N/A

Current Price

$1.37

Market Cap

34.5M

Sector

Health Care

ML Signal

N/A

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

N/A

Current Price

$0.61

Market Cap

43.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CELU
ICCM
Founded
2016
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.5M
43.4M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CELU
ICCM
Price
$1.37
$0.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$2.50
AVG Volume (30 Days)
28.0K
150.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$19.87
Revenue Next Year
$76.00
$31.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$0.54
52 Week High
$4.35
$1.53

Technical Indicators

Market Signals
Indicator
CELU
ICCM
Relative Strength Index (RSI) 57.21 49.55
Support Level $1.21 $0.59
Resistance Level $1.51 $0.62
Average True Range (ATR) 0.12 0.04
MACD 0.01 0.01
Stochastic Oscillator 69.75 45.31

Price Performance

Historical Comparison
CELU
ICCM

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: